6767
台微醫
+0.15 (+0.61%)24.651成交張數–本益比1.69股價淨值比0.00%殖利率2026-09-11資料日期
ROE 與 ROA
近四季合計;近十年
每股淨值
元
負債比率
負債總額 / 資產總額
現金流量
單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)
| 季度 | 資產總額(億) | 母公司權益(億) | 負債比率 | 流動比率 | 每股淨值 | ROE(近四季) | ROA(近四季) | 營業現金流(億) | 自由現金流(億) |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 7 | 6 | 17.8% | 10.37 | 14.60 | -2.9% | -2.4% | 0.0 | -0.1 |
| 2026Q1 | 7 | 6 | 18.4% | 9.47 | 14.70 | -3.6% | -2.9% | -0.1 | -0.2 |
| 2025Q4 | 7 | 6 | 19.4% | 8.57 | 14.62 | -3.3% | -2.6% | 0.1 | 0.1 |
| 2025Q3 | 7 | 6 | 17.3% | 11.49 | 15.12 | -3.2% | -2.5% | -0.1 | -0.1 |
| 2025Q2 | 7 | 6 | 18.1% | 10.37 | 15.03 | -5.9% | -4.7% | 0.0 | 0.0 |
| 2025Q1 | 7 | 6 | 17.1% | 12.01 | 15.24 | -6.1% | -4.8% | -0.1 | -0.1 |
| 2024Q4 | 7 | 6 | 19.2% | 7.04 | 15.11 | -10.2% | -8.0% | -0.1 | -0.1 |
| 2024Q3 | 5 | 3 | 28.1% | 3.98 | 11.59 | -11.3% | -8.2% | 0.0 | -0.0 |
| 2024Q2 | 5 | 3 | 26.9% | 4.51 | 11.93 | -11.1% | -8.2% | -0.1 | -0.1 |
| 2024Q1 | 5 | 4 | 27.2% | 4.49 | 12.24 | -6.8% | -5.0% | -0.2 | -0.2 |
| 2023Q4 | 5 | 4 | 25.5% | 4.96 | 12.74 | 0.4% | 0.3% | 0.0 | -0.0 |
| 2023Q3 | 5 | 4 | 26.2% | 4.84 | 12.99 | 0.9% | 0.7% | -0.1 | -0.2 |
| 2023Q2 | 5 | 4 | 26.1% | 4.19 | 13.33 | 4.2% | 3.1% | 0.0 | -0.1 |
| 2023Q1 | 5 | 4 | 25.4% | 4.79 | 13.09 | 1.1% | 0.8% | -0.1 | -0.2 |
| 2022Q4 | 5 | 4 | 26.7% | 4.67 | 12.69 | -4.5% | -3.4% | 0.0 | -0.0 |
| 2022Q3 | 5 | 4 | 25.9% | 5.11 | 12.87 | -3.6% | -2.9% | -0.0 | -0.2 |
| 2022Q2 | 5 | 4 | 25.0% | 5.41 | 12.78 | -6.3% | -5.2% | -0.1 | -0.2 |
| 2022Q1 | 5 | 4 | 23.9% | 5.71 | 12.94 | -8.9% | -7.3% | 0.0 | -0.2 |
| 2021Q4 | 5 | 4 | 23.2% | 5.56 | 13.26 | – | – | -0.0 | -0.1 |
| 2021Q3 | 4 | 4 | 13.0% | 6.72 | 13.33 | – | – | -0.0 | -0.0 |
| 2021Q2 | 4 | 4 | 10.0% | 10.27 | 13.60 | – | – | -0.1 | -0.2 |
| 2021Q1 | 5 | 4 | 9.6% | 11.11 | 14.13 | – | – | -0.0 | -0.0 |